Literature DB >> 6107405

Alpha lipoprotein (HDL) cholesterol in the serum and the risk of coronary heart disease and death.

A Keys.   

Abstract

The Minnesota Prospective Study on coronary heart disease (CHD) in 284 business and professional men began in 1947. In 1953 and 1955 measurements were made of serum alpha-lipoprotein (HDL) cholesterol on the men. The mean was 45 . 2 mg/dl, the same as reported for HDL cholesterol in men of that age at Framingham. As with HDL at Framingham and elsewhere, alpha cholesterol was not correlated with age, blood-pressure, total cholesterol, or smoking habit, but was negatively correlated (r=-0.37) with relative body-weight. In the next 25 years 133 men died, 55 from CHD. Mean alpha cholesterol of those who died from CHD was lower than that of men dying from other causes but was not significantly different from the mean of the 120 men alive in 1978. Of all groups classified by 25-year outcome, the 32 men who died from neoplasms had the highest mean alpha cholesterol at entry, differing significantly from survivors. Multivariate analysis did not change the relationships. Consideration of CHD only and follow-up of only a few years may greatly distort evaluation of the overall long-term significance of HDL cholesterol concentration in the plasma.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6107405     DOI: 10.1016/s0140-6736(80)90280-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  16 in total

1.  High density lipoprotein cholesterol is not a major risk factor for ischaemic heart disease in British men.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1986-04-12

2.  High density lipoprotein cholesterol is not a major risk factor for ischaemic heart disease in British men.

Authors:  S J Pocock; A G Shaper; A N Phillips; M Walker; T P Whitehead
Journal:  Br Med J (Clin Res Ed)       Date:  1986-02-22

Review 3.  Chronotherapy versus conventional statins therapy for the treatment of hyperlipidaemia.

Authors:  Jose Manuel Izquierdo-Palomares; Jesus Maria Fernandez-Tabera; Maria N Plana; Almudena Añino Alba; Pablo Gómez Álvarez; Inmaculada Fernandez-Esteban; Luis Carlos Saiz; Pilar Martin-Carrillo; Óscar Pinar López
Journal:  Cochrane Database Syst Rev       Date:  2016-11-26

Review 4.  High density lipoprotein cholesterol distribution and predictive power in some Italian populations studies.

Authors:  A Spagnolo; A Menotti; S Giampaoli; G Morisi; A Buongiorno; G C Urbinati; G Righetti; G Ricci
Journal:  Eur J Epidemiol       Date:  1989-09       Impact factor: 8.082

5.  Anacetrapib promotes reverse cholesterol transport and bulk cholesterol excretion in Syrian golden hamsters.

Authors:  Jose Castro-Perez; François Briand; Karen Gagen; Sheng-Ping Wang; Ying Chen; David G McLaren; Vinit Shah; Rob J Vreeken; Thomas Hankemeier; Thierry Sulpice; Thomas P Roddy; Brian K Hubbard; Douglas G Johns
Journal:  J Lipid Res       Date:  2011-08-14       Impact factor: 5.922

6.  The short term effects of bezafibrate on the hypertriglyceridaemia of moderate to severe uraemia.

Authors:  A J Williams; F Baker; J Walls
Journal:  Br J Clin Pharmacol       Date:  1984-09       Impact factor: 4.335

Review 7.  [Alterations of fat metabolism in renal disease - pathogenetic mechanisms (author's transl)].

Authors:  W H Hörl; M Hörl; A Heidland
Journal:  Klin Wochenschr       Date:  1982-04-01

8.  The myeloperoxidase product hypochlorous acid oxidizes HDL in the human artery wall and impairs ABCA1-dependent cholesterol transport.

Authors:  Constanze Bergt; Subramaniam Pennathur; Xiaoyun Fu; Jaeman Byun; Kevin O'Brien; Thomas O McDonald; Pragya Singh; G M Anantharamaiah; Alan Chait; John Brunzell; Randolph L Geary; John F Oram; Jay W Heinecke
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-23       Impact factor: 11.205

9.  High density lipoprotein cholesterol and longevity.

Authors:  A Keys
Journal:  J Epidemiol Community Health       Date:  1988-03       Impact factor: 3.710

10.  [Bezafibrate in primary hyperlipidemias (author's transl)].

Authors:  J G Wechsler; V Hutt; H U Klör; G Bode; H Ditschuneit
Journal:  Klin Wochenschr       Date:  1982-01-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.